Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Antimicrobial effect of natural polyphenols with or without antibiotics on Chlamydia pneumoniae infection in vitro.

Rizzo A, Carratelli CR, Losacco A, Iovene MR.

Microb Drug Resist. 2014 Feb;20(1):1-10. doi: 10.1089/mdr.2013.0024. Epub 2013 Aug 16.

PMID:
23952319
2.
3.

In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae.

Hammerschlag MR, Qumei KK, Roblin PM.

Antimicrob Agents Chemother. 1992 Jul;36(7):1573-4.

4.

Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro.

Salin OP, Pohjala LL, Saikku P, Vuorela HJ, Leinonen M, Vuorela PM.

J Antibiot (Tokyo). 2011 Nov;64(11):747-52. doi: 10.1038/ja.2011.79. Epub 2011 Sep 21.

PMID:
21934693
5.

In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.

Roblin PM, Hammerschlag MR.

Int J Antimicrob Agents. 2000 Sep;16(1):61-3.

PMID:
11185415
6.

In vitro susceptibilities of Chlamydia pneumoniae isolates from German patients and synergistic activity of antibiotic combinations.

Freidank HM, Losch P, Vögele H, Wiedmann-Al-Ahmad M.

Antimicrob Agents Chemother. 1999 Jul;43(7):1808-10.

7.
8.

Chlamydia pneumoniae resists antibiotics in lymphocytes.

Yamaguchi H, Friedman H, Yamamoto M, Yasuda K, Yamamoto Y.

Antimicrob Agents Chemother. 2003 Jun;47(6):1972-5.

9.

Effect of levofloxacin on the viability of intracellular Chlamydia pneumoniae and modulation of proinflammatory cytokine production by human monocytes.

Baltch AL, Smith RP, Ritz WJ, Carpenter AN, Bopp LH, Michelsen PB, Carlyn CJ, Hibbs JR.

Diagn Microbiol Infect Dis. 2004 Nov;50(3):205-12.

PMID:
15541607
10.
11.

Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures.

Alvesalo J, Vuorela H, Tammela P, Leinonen M, Saikku P, Vuorela P.

Biochem Pharmacol. 2006 Mar 14;71(6):735-41. Epub 2006 Jan 18.

PMID:
16414027
12.

In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model.

Kutlin A, Roblin PM, Hammerschlag MR.

Antimicrob Agents Chemother. 1999 Sep;43(9):2268-72.

13.

In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.

Kuo CC, Jackson LA, Lee A, Grayston JT.

Antimicrob Agents Chemother. 1996 Nov;40(11):2669-70.

14.

Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.

Caronzolo D, Lucini V, Pannacci M, Grosso S, Colleoni F, Fraschini F, Scaglione F.

Antimicrob Agents Chemother. 2004 Dec;48(12):4878-81.

15.

In-vitro susceptibility of Chlamydia pneumoniae (TWAR) to seven antibiotics.

Cooper MA, Baldwin D, Matthews RS, Andrews JM, Wise R.

J Antimicrob Chemother. 1991 Sep;28(3):407-13.

PMID:
1960121
16.
17.

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.

Critchley IA, Jones ME, Heinze PD, Hubbard D, Engler HD, Evangelista AT, Thornsberry C, Karlowsky JA, Sahm DF.

Clin Microbiol Infect. 2002 Apr;8(4):214-21.

18.

Levofloxacin kills Chlamydia pneumoniae and modulates interleukin 6 production by HEp-2 cells.

Baltch AL, Smith RP, Ritz WJ, Carpenter-Knaggs A, Michelsen PB, Carlyn CJ, Bopp LH, Hibbs JR.

Chemotherapy. 2003 May;49(1-2):27-32.

PMID:
12714806
19.

Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae.

Riska PF, Kutlin A, Ajiboye P, Cua A, Roblin PM, Hammerschlag MR.

Antimicrob Agents Chemother. 2004 Sep;48(9):3586-90.

20.

The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae.

Hammerschlag MR, Roblin PM.

J Antimicrob Chemother. 2004 Jul;54(1):281-2. Epub 2004 Jun 9. No abstract available.

PMID:
15190026

Supplemental Content

Support Center